ArticleOncotarget2017

ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.

Xiupeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.